DOW JONES21,026.75-386.69 -1.81%
S&P 5002,480.35-46.55 -1.84%
NASDAQ7,314.16-173.16 -2.31%

Raymond James Maintains Strong Buy on ChemoCentryx, Raises Price Target to $64

Raymond James maintains ChemoCentryx (NASDAQ:CCXI) with a Strong Buy and raises the price target from $56 to $64.

Benzinga · 03/11/2020 11:17

Raymond James maintains ChemoCentryx (NASDAQ:CCXI) with a Strong Buy and raises the price target from $56 to $64.